A case of schizophrenia with relapsed catatonia successfully treated with blonanserin transdermal patch.

Published in: Neuropsychopharmacology reports (2023)

Although benzodiazepines or electroconvulsive therapy have been recommended as the first-line treatment of catatonic manifestation observed in psychiatric patients, this patient responded well to antipsychotic blonanserin. From the differential drug responses, catatonia may be the complex of heterogeneous conditions with different pathophysiologies.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
bipolar disorder
acute lymphoblastic leukemia
acute myeloid leukemia
mental health
case report
multiple myeloma
hodgkin lymphoma
drug induced